Nurix Therapeutics, Inc. (NRIX) NASDAQ

19.36

+0.07(+0.36%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap1.48B
Enterprise Value1.4B
P/E Ratio-6.66
PEG Ratio0.48
Price/Sales Ratio17.78
Price/Book Ratio4.38
Enterprise/Revenue17.52
Enterprise/EBITDA-5.83

Fiscal Year

Fiscal YearNovember 30, 2024
Most Recent QuarterAugust 31, 2025

Profitability

Profit Margin-2.93
Operating Margin-3.19

Management Effectiveness

Return On Assets-0.47
Return On Equity-0.54

Income Statement

Revenue54.55M
Revenue/Share0.99
Gross Profit-167.08M
EBITDA-205.01M
Net Income-193.57M
Diluted EPS-2.88

Balance Sheet

Total Cash428.83M
Total Cash/Share5.1
Total Debt56.49M
Total Debt/Equity0.15
Current Ratio5.35
Book Value Per Share4.42

Price History

52-Week Change-1.07
52-Week High22.5
52-Week Low8.18
Moving Average 50 Days14.71
Moving Average 200 Days11.78

Statistics

Average Volume1.8M
Shares Outstanding76.88M
% Held by Institutions100.73

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A